Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,856 | -2,640 | -8,368 | -5,474 | -3,542 |
| Depreciation Amortization | -633 | -792 | -1,525 | -1,496 | -944 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -1,641 |
| Accounts receivable | 220 | 474 | 120 | 666 | 103 |
| Other Working Capital | 264 | 1,126 | 2,500 | 2,303 | 1,008 |
| Other Operating Activity | 694 | 371 | -1,308 | -2,167 | 336 |
| Operating Cash Flow | $-6,311 | $-1,461 | $-8,581 | $-6,168 | $-4,680 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -6 | -29 | -24 | -19 |
| Purchase Sale Intangibles | N/A | N/A | -609 | -490 | -490 |
| Other Investing Activity | 0 | 0 | -629 | -510 | -490 |
| Investing Cash Flow | $-48 | $-6 | $-658 | $-534 | $-509 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 54,287 | 34,200 | 54,241 |
| Other Financing Activity | -68 | -34 | -3,250 | 16,726 | -3,284 |
| Financing Cash Flow | $-68 | $-34 | $51,037 | $50,926 | $50,957 |
| Exchange Rate Effect | -716 | -203 | -769 | -493 | -171 |
| Beginning Cash Position | 65,300 | 65,300 | 24,271 | 24,271 | 24,271 |
| End Cash Position | 58,157 | 63,596 | 65,300 | 68,002 | 69,868 |
| Net Cash Flow | $-7,143 | $-1,704 | $41,029 | $43,731 | $45,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,311 | -1,461 | -8,581 | -6,168 | -4,680 |
| Capital Expenditure | -48 | -6 | -30 | -25 | -20 |
| Free Cash Flow | -6,359 | -1,467 | -8,611 | -6,193 | -4,700 |